We are live on
!
Find out more
iShares Biotechnology ETF
253 hedge funds and large institutions have $2.6B invested in iShares Biotechnology ETF in 2013 Q3 according to their latest regulatory filings, with 44 funds opening new positions, 86 increasing their positions, 76 reducing their positions, and 21 closing their positions.
New
Increased
Maintained
Reduced
Closed
110% more first-time investments, than exits
New positions opened: 44 | Existing positions closed: 21
25% more call options, than puts
Call options by funds: $184M | Put options by funds: $147M
20% more funds holding in top 10
Funds holding in top 10: 10 → 12 (+2)
15% more capital invested
Capital invested by funds: $2.26B → $2.6B (+$343M)
13% more repeat investments, than reductions
Existing positions increased: 86 | Existing positions reduced: 76
9% more funds holding
Funds holding: 232 → 253 (+21)
Holders
253
Holders Change
+21
Holders Change %
+9.05%
% of All Funds
8.2%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.39%
New
44
Increased
86
Reduced
76
Closed
21
Calls
$184M
Puts
$147M
Net Calls
+$37.3M
Net Calls Change
+$123M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$28.3M |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$24.7M |
| 3 |
TCM
Tekla Capital Management
Boston,
Massachusetts
|
+$16.5M |
| 4 |
LPL Financial
San Diego,
California
|
+$9.79M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$9.75M |
Top Sellers
| 1 |
Morgan Stanley
New York
|
-$92.5M |
| 2 |
Bank of Nova Scotia
Toronto,
Ontario, Canada
|
-$65M |
| 3 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$53.3M |
| 4 |
Allianz Asset Management
Munich,
Germany
|
-$33M |
| 5 |
JP Morgan Chase
New York
|
-$15.9M |
